Document Detail

Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial).
MedLine Citation:
PMID:  15721102     Owner:  NLM     Status:  MEDLINE    
White blood cell (WBC) count and temperature are 2 global measures of inflammation that are systematically gathered and easily identifiable in a clinical setting, unlike many other markers of inflammation being investigated in patients with coronary artery disease. The prognostic usefulness of the WBC count and temperature were evaluated in a large acute myocardial infarction trial, the Complement And ReDuction of INfarct size after Angioplasty or Lytics program. Baseline and serial measurements of WBC counts and temperature were correlated with infarct size and clinical outcome.
Manesh R Patel; Kenneth W Mahaffey; Paul W Armstrong; W Douglas Weaver; Gudaye Tasissa; Judith S Hochman; Thomas G Todaro; Kevin J Malloy; Scott Rollins; Pierre Theroux; Witold Ruzyllo; Jose C Nicolau; Christopher B Granger;
Publication Detail:
Type:  Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The American journal of cardiology     Volume:  95     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-02-21     Completed Date:  2005-03-24     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  614-8     Citation Subset:  AIM; IM    
Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibodies, Monoclonal / therapeutic use
Area Under Curve
Body Temperature*
Chi-Square Distribution
Creatine Kinase / blood
Leukocyte Count*
Linear Models
Myocardial Infarction / immunology*,  mortality,  therapy
Predictive Value of Tests
Survival Analysis
Thrombolytic Therapy
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/h5G1.1-scFv; EC Kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor t...
Next Document:  Prognostic significance of simvastatin therapy in patients with ischemic heart failure who underwent...